Hepatitis C Research
- 99% Cure Rates for AbbVie's Hep C Combo in Genotype 1b (March 6, 2014)
From AIDSmeds.com
 "3D" Combo Drug Cures 99% of Hepatitis C, Without Interferon and Ribavirin (March 6, 2014)
In The 21st Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Triple-DAA Combo (a Possible 3-in-1 Pill) Yields SVRs Over 90% After 12 Weeks (March 5, 2014)
From National AIDS Treatment Advocacy Project
- Sofosbuvir With Ribavirin in Gt1/2/3 HCV/HIV Coinfected Patients (March 5, 2014)
From National AIDS Treatment Advocacy Project
- HIV Transmission Bottleneck Offers Clue to HCV Epidemic in HIV+ MSM (March 5, 2014)
From National AIDS Treatment Advocacy Project
- Sofosbuvir and Ribavirin Cures 75% of Genotype 1 HIV/HCV Co-Infected Patients (March 5, 2014)
From aidsmap.com
- All-Oral HCV Regimen Works in 9 Out of 10 (March 4, 2014)
From MedPage Today
- Double or Triple DAA Therapy for HCV-1 Yields 95-100% SVRs in 6 or 12 Weeks (SYNERGY Study) (March 4, 2014)
From National AIDS Treatment Advocacy Project
- SVR12 72% With Faldaprevir Plus PegIFN/RBV in Naives With HCV/HIV (March 4, 2014)
From National AIDS Treatment Advocacy Project
- Simeprevir Plus PegIFN/RBV Yields 74% SVR12 in HCV/HIV Patients (March 4, 2014)
From National AIDS Treatment Advocacy Project
VIEW ALL ARTICLES
|
Advertisement
|
Email
Glossary
